BRAF recruitment to spinal sensory synapses promotes neuropathic pain by potentiating transsynaptic NMDA receptor activity
- 25 August 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 19 (952)
Abstract
Sustained hyperactivity of synaptic NMDA receptors (NMDARs) in the spinal dorsal horn is a hallmark of chronic neuropathic pain. Here, we identified the kinase BRAF as a critical regulator of this process. Spinal nerve injury in rats induced the translocation of BRAF from the dorsal root ganglion (DRG) to spinal cord synaptosomes, which was associated with enhanced phosphorylation of the downstream kinases MEK and ERK. In addition, spinal cord injury increased the interaction between NMDARs and BRAF/MEK/ERK in spinal cord samples from rats and humans. Pharmacological inhibition or genetic ablation of BRAF in mouse DRG neurons reversed nerve injury–induced NMDAR phosphorylation, synaptic trafficking, and presynaptic and postsynaptic hyperactivity in the spinal dorsal horn. Furthermore, whereas pain hypersensitivity persisted in wild-type mice after nerve injury, it was transient and less severe in mice that either lacked BRAF in DRG neurons or were treated with BRAF pathway inhibitors. Conversely, expressing a constitutively active BRAF mutant in DRG neurons induced sustained nociceptive hypersensitivity, which was blocked by NMDAR antagonists, gabapentin, or an α2δ-1 C-terminal-interfering peptide. This was accompanied by increased NMDAR phosphorylation and enhanced pre- and postsynaptic activity in the spinal cord. These findings reveal that BRAF in sensory neurons promotes neuropathic pain by enhancing NMDAR phosphorylation and transsynaptic hyperactivity and suggest that BRAF inhibitors might be repurposed to treat neuropathic pain.Keywords
Funding Information
- NIH (NS132398)
- NIH (NS101880)
This publication has 64 references indexed in Scilit:
- Targeting oncogenic Raf protein-serine/threonine kinases in human cancersPharmacological Research, 2018
- The α2δ-1-NMDA Receptor Complex Is Critically Involved in Neuropathic Pain Development and Gabapentin Therapeutic ActionsCell Reports, 2018
- Chloride Homeostasis Critically Regulates Synaptic NMDA Receptor Activity in Neuropathic PainCell Reports, 2016
- Selective inhibition of extracellular signal-regulated kinases 1/2 blocks nerve growth factor to brain-derived neurotrophic factor signaling and suppresses the development of and reverses already established pain behavior in ratsNeuroscience, 2012
- Protein kinase C α trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2Cancer Letters, 2006
- Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the ratNeuroscience Letters, 2006
- Forebrain-specific knockout of B-raf kinase leads to deficits in hippocampal long-term potentiation, learning, and memoryJournal of Neuroscience Research, 2005
- Enhancement of NMDA receptor phosphorylation of the spinal dorsal horn and nucleus gracilis neurons in neuropathic ratsPain, 2005
- Vimentin-Dependent Spatial Translocation of an Activated MAP Kinase in Injured NerveNeuron, 2005
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994